Table 1 Baseline characteristics of the two groups of study patients
Characteristics | Study groups | |
|---|---|---|
Vitamin A supplementation (n = 15) | Non-vitamin A supplementation (n = 15) | |
Age, mean years ± SD | 9.6 ± 4.3 | 7.8 ± 2.5 |
Male, n (%) | 10 (66.7) | 7 (46.7) |
Underlying disease, n (%) | ||
Malignant disease | 7 (46.7) | 5 (33.3) |
Nonmalignant disease | 8 (53.3) | 10 (66.7) |
Type of HSCT, n (%) | ||
Haploidentical | 10 (66.7) | 10 (66.7) |
Non-haploidentical | 5 (33.3) | 5 (33.3) |
Weight for height, mean % ± SD | 102.4 ± 18.63 | 97.9 ± 26.07 |
Baseline plasma retinol (µg/dL), mean ± SD | 44.1 ± 21.4 | 47.9 ± 19.3 |
Plasma retinol < 30 µg/dL, n (%) | 5 (33.3) | 2 (13.3) |
Baseline plasma citrulline (μmol/L), mean ± SD | 25.7 ± 10.8 | 29.2 ± 8 |